VOYA Investment Management
CLSD

VOYA Investment Management’s Clearside Biomedical CLSD Stock Holding History

VOYA Investment Management’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-766
Closed -$16K – 2587
2019
Q1 		$16K Hold
766
– – ﹤0.01% 2550
2018
Q4 		$12K Hold
766
– – ﹤0.01% 2545
2018
Q3 		$71K Hold
766
– – ﹤0.01% 2535
2018
Q2 		$123K Buy
+766
New +$129K ﹤0.01% 2478

Other funds holding CLSD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

VOYA Investment Management's CLSD Position: Q2 2019 in Review

VOYA Investment Management sold out of Clearside Biomedical (CLSD) in Q2 2019, closing a stake of 766 shares — an estimated $16K sold.

VOYA Investment Management first reported a position in CLSD in Q2 2018 and held it in 4 quarters. The position peaked at $123K in Q2 2018. 50 funds tracked by Wall St. Rank hold CLSD as of Q2 2019.

  • VOYA Investment Management reported no remaining Clearside Biomedical position as of Q2 2019 after selling out during the quarter.
  • VOYA Investment Management sold 766 Clearside Biomedical shares in Q2 2019, an estimated $16K.
  • VOYA Investment Management first reported a position in Clearside Biomedical in Q2 2018 and held it in 4 quarters.
  • VOYA Investment Management's Clearside Biomedical position peaked at $123K in Q2 2018.
  • 50 funds tracked by Wall St. Rank held Clearside Biomedical as of Q2 2019.

Based on VOYA Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.